Perhaps the biggest shift Pharma has seen in the last 2 years is the Inflation Reduction Act (IRA) of 2022. While there are several elements to this bill, here are 3 that have a very important and immediate impact.
Medicare Drug Price Negotiation
The IRA grants Medicare the authority to negotiate prices directly with pharmaceutical companies for certain high-cost drugs. This is a major shift, as previously, Medicare was prohibited from negotiating drug prices. The team at D2 is hearing that some of these discounts might approach as much as 80%. Read More >
D2 Solutions empowers healthcare leaders with a unique combination of SaaS solutions and deep consulting expertise. We bring pharmaceutical manufacturers, payers, pharmacies & support providers, and patients together. It’s an approach we call, “The Point of Progress.” That’s both a promise and a call to action, empowering manufacturers to bring therapies to market faster and pharmacies to bring those therapies to the patients who need them. We lead manufacturers through the commercialization process, adding value to Trade & Distribution, Market Access & Reimbursement, and Patient Services. We also stand with pharmacies and hospital IDNs, providing the guidance they need to achieve compliance and licensure, solve regulatory challenges, and better connect with patients. Our proprietary technologies move clients even closer to their goals, finding that one point where everything moves forward.
This post is related to:
Practice Setting: Community / Retail Pharmacy Resources Practice Setting: Health System Pharmacy Resources Practice Setting: Infusion Pharmacy Resources Practice Setting: Long-Term Care Pharmacy Resources Practice Setting: Specialty Pharmacy Resources Professional Services: Accreditation, Certification, Compliance Professional Services: Audit Support Professional Services: Consulting (Health Systems & Infusion) Professional Services: Consulting (Retail/Community & Specialty)
